Authors: Schinkel, J Kroes, ACM Wagtmans, MJ Lamers, CBHW van Hoek, B

Citation: J. Schinkel et al., Monitoring response during a randomised controlled trial of escalating interferon dose for chronic hepatitis C infection: predictive value of quantitative and qualitative HCV RNA assays, J CLIN VIRO, 22(1), 2001, pp. 61-71

Authors: van der Werf, MJ Schinkel, J van Santen, G Vergouwe, I Wix, RA van Ameijden, EJ

Citation: Mj. Van Der Werf et al., Highly active antiretroviral therapy among drug users in Amsterdam: self-perceived reasons for not receiving therapy, AIDS, 13(10), 1999, pp. 1280-1281

Authors: Schinkel, J Langendam, MW Coutinho, RA Krol, A Brouwer, M Schuitemaker, J

Citation: J. Schinkel et al., No evidence for an effect of the CCR5 Delta 32/+ and CCR2b 64I/+ mutationson human immunodeficiency virus (HIV)-1 disease progression among HIV-1-infected injecting drug users, J INFEC DIS, 179(4), 1999, pp. 825-831